Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports

ConclusionsThese case reports indicate that cabozantinib was able, first, to reach brain tumors and second, to induce significant regressions in renal carcinoma brain metastases that were resistant to radiation as well as to previous systemic vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research